OTSUKA PHARMASEUTICAL INDIA PVT.LTD

Company Introduction: OTSUKA PHARMACEUTICAL INDIA PVT. LTD.

OTSUKA PHARMACEUTICAL INDIA PVT. LTD. (OPI) is a significant subsidiary of Otsuka Pharmaceutical Co., Ltd., Japan, a global healthcare company. OPI is a prominent player in the Indian pharmaceutical industry, specializing in the manufacturing and marketing of a wide range of pharmaceutical products. Its core focus areas include intravenous (IV) solutions, clinical nutrition products, and other essential pharmaceuticals.

The company operates modern, state-of-the-art manufacturing facilities in India, such as its plant located in Ahmedabad, Gujarat. These facilities are dedicated to producing high-quality large volume parenterals (LVPs), small volume parenterals (SVPs), and various formulations for clinical nutrition and other therapeutic areas. OPI is committed to delivering innovative and quality healthcare solutions to improve the health and well-being of patients across India. In addition to manufacturing, OPI is also actively involved in the robust distribution and marketing of its products to hospitals, healthcare institutions, and clinics throughout the country.

Nature of Business: Factory (Manufacturer)

OTSUKA PHARMACEUTICAL INDIA PVT.LTD. manufactures and sells the following products:

Intravenous Infusions (IV Fluids):

Dextrose Injections (various concentrations such as Dextrose 5 percent, Dextrose 10 percent, Dextrose 25 percent)

Sodium Chloride Injections (various concentrations such as Sodium Chloride 0.9 percent)

Ringer's Lactate Injection

Dextrose and Sodium Chloride Injections

Amino Acid Solutions for Parenteral Nutrition

Fat Emulsions for Parenteral Nutrition

Electrolyte Solutions

Multi-Vitamin Infusions

Oral Rehydration Solution (ORS):

Otsuka ORS (Oral Rehydration Salts) powder or liquid formulations for rehydration therapy.